Emily Russell

Emily Russell

Auto-generated profile, based on publicly available information

Emily Russell

Affiliation Buckinghamshire Healthcare NHS Trust, Aylesbury, Buckinghamshire, United Kingdom

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in International Journal of Cardiology
Verified
Journal Article
Closed access
CCC. Fielder Camm
C. Fielder Camm
EREmily Russell
Emily Russell
AJAntonio Ji-Xu
Antonio Ji-Xu
KRKim Rajappan
Kim Rajappan

9 September 2023 in JHEP Reports
Verified
Journal Article
Open access
SWSuz Warner
Suz Warner
JRJeremy Rajanayagam
Jeremy Rajanayagam
EREmily Russell
Emily Russell
CLCarla Lloyd
Carla Lloyd
JFJames Ferguson
James Ferguson
GHGideon M. Hirschfield
Gideon M. Hirschfield
Long-term follow-up studies of paediatric onset autoimmune liver disease (AILD) are invaluable in helping better understand the clinical course of disease. In day-to-day practice clinicians struggle with disease definitions whilst patients and parents lack clear prognostic information. The clinical progression of 159 patients with childhood onset AILD between June 1990 and December 2013 was reviewed, capturing data up to adulthood (ending May 2021). Presentation with autoimmune hepatitis (AIH) was dominant (n = 119); biliary presentations accounted for 25%. During follow up, biliary disease progression confirmed by cholangiography and/or liver histology was observed frequently: 19.8% (20/101) patients with childhood onset AIH type 1 (AIH-1) developed biliary features by adulthood and of these 50% phenotypically transitioned to primary sclerosing cholangitis (PSC); the remaining transitioned to an overlap disease phenotype. No patients with AIH type 2 developed biliary progression. Two-thirds of patients with overlap features (14/21) in childhood had phenotypically progressed to PSC by adulthood. Approximately 43% (6/14) of AIH-1 patients requiring a liver transplant in adulthood had explant evidence of biliary disease compared with 11% (1/9) in childhood, whereas 35.7% (5/14) of patients had histology diagnostic of PSC in their explant liver and 7.1% (1/14) had overlap features. All patients with biliary phenotypes (PSC, autoimmune sclerosing cholangitis, overlap) who required a transplant (n = 18) were found to have explant histology consistent with PSC. Twelve of 14 patients with biliary progression developed ulcerative colitis during follow-up with 92% progressing to PSC. Three decades of follow-up demonstrated how children presenting with AILD had a significant risk of clinical transformation to PSC. Biliary progression was significantly associated with the development of inflammatory bowel disease. Childhood onset autoimmune liver disease remains very impactful for patients and families. Disease nomenclature can however be confusing. Long-term follow up studies as children become adults is important to help understand how and why disease behaves over time. Understanding more about the long-term course of childhood autoimmune liver disease will help patients, families and doctors striving to improve care and reduce poor clinical outcomes. We followed over 150 patients with childhood onset autoimmune liver diseases into adulthood. We found that amongst patients with classical autoimmune hepatitis, 1 in 5 developed biliary disease over time, mostly consisting of primary sclerosing cholangitis. This was associated with developing inflammatory bowel disease. Our study design was retrospective and has relevant limitations. Defining phenotypes of autoimmune liver diseases is difficult and there is insufficient consensus, especially between adult and childhood physicians. Our data confirms the critical importance of careful long-term follow-up of patients, including safe transition to adult care, as well as robustly demonstrates, using real-world data, how disease nature can change over time. Our study affirms the need for investment in prospective cohort studies.

13 April 2022 in Pediatric Dermatology
Verified
Journal Article
Closed access
EREmily A. Russell
Emily A. Russell
SBSophie Bennett
Sophie Bennett
RARukshana Ali
Rukshana Ali
SBSusannah Baron
Susannah Baron
CFCarsten Flohr
Carsten Flohr
JRJane C. Ravenscroft
Jane C. Ravenscroft


5 August 2020 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
ERE. Russell
E. Russell
SWS. Walker
S. Walker
TMT. McPherson
T. McPherson
We were pleased that the first national guidelines for paediatric Stevens‐Johnson Syndrome (SJS) / Toxic Epidermal Necrolysis (TEN) were published in your journal last year1. They highlighted the higher rate of infectious triggers in children compared to adults. This message is especially important for us, as author SW’s son had SJS/TEN triggered by Mycoplasma pneumoniae, which accounts for up to 50% of infectious causes. SW experienced first‐hand the frustration of aetiological uncertainty in this disease. Accurate diagnosis of Mycoplasma‐induced SJS/TEN is important as it allows for continuation of simple analgesia (otherwise implicated as a possible trigger), possible avoidance of further drug allergy testing (which can be inconclusive), focused treatment of Mycoplasma with antibiotics, and management of recurrence risk.

24 March 2025 in medRxiv
Verified
Preprint
Open access
PDF file
STSusanna Tucker
Susanna Tucker
NHNicola R Heneghan
Nicola R Heneghan
ARAlison Rushton
Alison Rushton
AGAdrian Gardner
Adrian Gardner
EREmily Russell
Emily Russell
Andrew SoundyAndrew Soundy
Andrew Soundy
Introduction Physiotherapists and surgeons have a significant role in promoting participation and offering a graded return to sports, exercise, and physical activity following spinal fusion in adolescent idiopathic scoliosis (AIS). However, there is a lack of evidence to guide post-operative rehabilitation and variability worldwide. This study aims to obtain consensus on 1) when it is safe and 2) how an individual with AIS might return to sports, exercise, and physical activity. Methods and analysis An international electronic 3 round Delphi study was conducted and reported. Eligible expert surgeons or physiotherapists had either specific clinical or research experience in AIS. Round 1 included a series of open-ended questions. Round 2 provided a summary of the existing literature for participants to review and rate items. Round 3 participants were asked to re-rate responses. Consensus was determined through content analysis of open statements >1 participant, round 2 statements achieving >75% on a 5-point Likert scale, and round 3 Kendall’s coefficient of concordance. Results From 53 recruited participants (18 countries, 1 unknown), 41 responded to round 1, 32 to round 2, and 29 to Round 3 (14 surgeons, 15 physiotherapists). Round 1 generated 85 statements under 19 themes surrounding graded return to sports, rehabilitation milestones, philosophical approaches, and treatment modalities. Round 2 generated 63 statements with >75% agreement. Round 2 open comments generated 22 statements. The 66 statements agreed in round 3 generated 9 themes with corresponding statements regarding different phases of care. All round 3 statements demonstrated significant (p<0.001) moderate agreement (W=0.5). A Wilcoxon Sum-rank result (p<0.05) showed stability between rounds 2 and 3. An additional 5 statements (total 71 statements) were generated from round 3 open comments. Conclusion This Delphi study provides the first international consensus of 71 statements on return to sports, exercise, and physical activity following spinal fusion in AIS.